Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

OCEL

Organicell Regenerative ... (QB) (OCEL)

Organicell Regenerative Medicine Inc (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:OCEL
DataHoraFonteTítuloCódigoCompanhia
27/11/202319:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
19/10/202307:56Edgar (US Regulatory)Form PRER14C - Information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
28/09/202315:54Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/09/202317:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
25/08/202316:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/08/202317:34Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
11/07/202317:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202310:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
28/06/202317:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
16/06/202317:07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/06/202317:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
09/06/202317:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/02/202318:59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/02/202318:39Edgar (US Regulatory)Annual Report (10-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
30/12/202215:46Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
17/11/202210:38InvestorsHub NewsWireOrganicell Starts Enrolling Long COVID TrialUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/11/202210:52InvestorsHub NewsWireOrganicell Activates COPD Trial at Mayo ClinicUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
03/11/202218:02Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
20/10/202218:10Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
30/12/202118:14Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
21/07/201515:17Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
21/05/201515:38Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
19/09/201302:04OTC MarketsOcean Electric, Inc. (OCELE: OTCQB) | Symbol ChangeUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
18/09/201301:00OTC MarketsTier ChangeUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/08/201307:00Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
05/06/201307:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
02/04/201307:13Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
10/01/201317:02Edgar (US Regulatory)Current report filing (8-K)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
08/01/201319:12Edgar (US Regulatory)Amended Current report filing (8-K/A)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
08/01/201319:12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:OCEL